The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Dietary Intervention in Infancy and Later Signs of Beta-Cell Autoimmunity
Open accessAbstract
BACKGROUND: Early exposure to complex dietary proteins may increase the risk of beta-cell autoimmunity and type 1 diabetes in children with genetic susceptibility. We tested the hypothesis that supplementing breast milk with highly hydrolyzed milk formula would decrease the cumulative incidence of diabetes-associated autoantibodies in such children. METHODS: In this double-blind, randomized trial, we assigned 230 infants with HLA-conferred susceptibility to type 1 diabetes and at least one family member with type 1 diabetes to receive either a casein hydrolysate formula or a conventional, cow's-milk-based formula (control) whenever breast milk was not available during the first 6 to 8 months of life. Autoantibodies to insulin, glutamic acid decarboxylase (GAD), the insulinoma-associated 2 molecule (IA-2), and zinc transporter 8 were analyzed with the use of radiobinding assays, and islet-cell antibodies were analyzed with the use of immunofluorescence, during a median observation period of 10 years (mean, 7.5). The children were monitored for incident type 1 diabetes until they were 10 years of age. RESULTS: The unadjusted hazard ratio for positivity for one or more autoantibodies in the casein hydrolysate group, as compared with the control group, was 0.54 (95% confidence interval [CI], 0.29 to 0.95), and the hazard ratio adjusted for an observed difference in the duration of exposure to the study formula was 0.51 (95% CI, 0.28 to 0.91). The unadjusted hazard ratio for positivity for two or more autoantibodies was 0.52 (95% CI, 0.21 to 1.17), and the adjusted hazard ratio was 0.47 (95% CI, 0.19 to 1.07). The rate of reported adverse events was similar in the two groups. CONCLUSIONS: Dietary intervention during infancy appears to have a long-lasting effect on markers of beta-cell autoimmunity--markers that may reflect an autoimmune process leading to type 1 diabetes. (ClinicalTrials.gov number, NCT00570102.).
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Children who received the hydrolysed formula were less likely to develop two or more islet autoantibodies compared with those who received the conventional formula, with an unadjusted hazard ratio of 0·52.128”
From Type 1 diabetes (2014) · cites this paper as [128]
The cited source says what the claim attributes to it.
In the citing paper
“A study in Finland128 identified 230 infants with a first-degree relative with type 1 diabetes, and randomly assigned infants to receive a hydrolysed infant formula or conventional formula whenever breast milk was not available during the first 6–8 months of life.”
From Type 1 diabetes (2014) · cites this paper as [128]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Patterson, C. C., Dahlquist, G. G., Gyürüs, E., Green, A., & Soltész, G. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60568-7 · Cited by 1,854
The Empirical Distribution Function with Arbitrarily Grouped, Censored and Truncated Data
Turnbull, B. W. (1976) · Journal of the Royal Statistical Society Series B (Statistical Methodology) · doi:10.1111/j.2517-6161.1976.tb01597.x · Cited by 1,835
Royston, P. J., & Parmar, M. (2002) · Statistics in Medicine · doi:10.1002/sim.1203 · Cited by 1,537
The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes
Wenzlau, J. M., Juhl, K., Yu, L., Moua, O., Sarkar, S. A., Gottlieb, P., Rewers, M., Eisenbarth, G. S., Jensen, J., Davidson, H. W., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0705894104 · Cited by 1,014
Time trends in the incidence of type 1 diabetes in Finnish children: a cohort study
Harjutsalo, V., Sjöberg, L., & Tuomilehto, J. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60765-5 · Cited by 666
Ziegler, A., Hummel, M., Schenker, M., & Bonifacio, E. E. (1999) · Diabetes · doi:10.2337/diabetes.48.3.460 · Cited by 640
Early Infant Feeding and Risk of Developing Type 1 Diabetes–Associated Autoantibodies
Ziegler, A. (2003) · JAMA · doi:10.1001/jama.290.13.1721 · Cited by 562
Timing of initial cereal exposure in infancy and risk of islet autoimmunity
Norris, J. M. (2003) · JAMA · doi:10.1001/jama.290.13.1713 · Cited by 515
Nutritional risk predictors of β cell autoimmunity and type 1 diabetes at a young age
Virtanen, S. M., & Knip, M. (2003) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/78.6.1053 · Cited by 220
Self-citationKimpimäki, T., Kupila, A., Hämäläinen, A.-M., Kukko, M., Kulmala, P., Savola, K., Simell, T. T., Keskinen, P., Ilonen, J., Simell, O., et al. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.10.7907 · Cited by 207
Self-citationVirtanen, S. M., Kenward, M. G., Erkkola, M., Kautiainen, S., Kronberg‐Kippilä, C., Hakulinen, T. R., Ahonen, S., Uusitalo, L., Niinistö, S., Veijola, R., et al. (2006) · Diabetologia · doi:10.1007/s00125-006-0236-1 · Cited by 166
Self-citationTriple-label hybridization assay for type-1 diabetes-related HLA alleles.
Sjöroos, M., Iitiä, A., Ilonen, J., Reijonen, H., & Lövgren, T. N.-E. (1995) · PubMed · Cited by 165
Self-citationInfant Feeding in Finnish Children <7 yr of Age With Newly Diagnosed IDDM
Virtanen, S. M., Räsänen, L., Aro, A., Lindström, J., Sippola, H., Lounamaa, R., Toivanen, L., Tuomilehto, J. O., Åkerblom, H. K., & Childhood Diabetes in Finland Study Group (1991) · Diabetes Care · doi:10.2337/diacare.14.5.415 · Cited by 161
Self-citationInfant feeding and the risk of type 1 diabetes
Knip, M., Virtanen, S. M., & Åkerblom, H. K. (2010) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.2010.28701c · Cited by 156
Self-citationÅkerblom, H. K., Virtanen, S. M., Ilonen, J., Savilahti, E., Vaarala, O., Reunanen, A., Teramo, K., Hämäläinen, A.-M., Paronen, J., Riikjärv, M. ‐., et al. (2005) · Diabetologia · doi:10.1007/s00125-005-1733-3 · Cited by 145
Self-citationIlonen, J., Reijonen, H., Herva, E., Sjöroos, M., Iitiä, A., Lövgren, T. N.-E., Veijola, R., Knip, M., Åkerblom, H. K., & The Childhood Diabetes in Finland (DIME) Study Group (1996) · Diabetes Care · doi:10.2337/diacare.19.8.795 · Cited by 137
Self-citationSiljander, H., Simell, S., Hekkala, A., Lähde, J., Simell, T. T., Vähäsalo, P., Veijola, R., Ilonen, J., Simell, O., & Knip, M. (2009) · Diabetes · doi:10.2337/db08-1305 · Cited by 133
Self-citationKukko, M., Kimpimäki, T., Korhonen, S., Kupila, A., Simell, S., Veijola, R., Simell, T., Ilonen, J., Simell, O., & Knip, M. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1371 · Cited by 116
Self-citationStudy design of the Trial to Reduce IDDM in the Genetically at Risk (TRIGR)
The TRIGR Study Group* (2007) · Pediatric Diabetes · doi:10.1111/j.1399-5448.2007.00239.x · Cited by 107
Natural Course of Preclinical Type 1 Diabetes
Knip, M. (2002) · Hormone Research in Paediatrics · doi:10.1159/000053305 · Cited by 99
Self-citationFamilial Risk of Type I diabetes in European Children
The EURODIAB ACE Study Group and The EURODIAB ACE Substudy 2 Study Group (1998) · Diabetologia · doi:10.1007/s001250051044 · Cited by 95
Holmberg, H., Wahlberg, J., Vaarala, O., Ludvigsson, J., & for the ABIS study group (2007) · British Journal Of Nutrition · doi:10.1017/s0007114507210189 · Cited by 84
Self-citationKimpimäki, T. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.10.4782 · Cited by 74
Nationwide survey of comorbidity, use, and costs of all medications in Finnish diabetic individuals.
Reunanen, A., Kangas, T., Martikainen, J. E., & Klaukka, T. (2000) · Diabetes Care · doi:10.2337/diacare.23.9.1265 · Cited by 71
Self-citationKarges, W., Hammond-McKibben, D., Cheung, R. K., Visconti, M., Shibuya, N., Kemp, D., & Dosch, H. (1997) · Diabetes · doi:10.2337/diab.46.4.557 · Cited by 70
Self-citationDietary Cow's Milk Protein Does Not Alter the Frequency of Diabetes in the BB Rat
Malkani, S., Nompleggi, D. J., Hansen, J. W., Greiner, D. L., Mordes, J. P., & Rossini, A. A. (1997) · Diabetes · doi:10.2337/diab.46.7.1133 · Cited by 52
Can We Predict Type 1 Diabetes in the General Population?
Knip, M. (2002) · Diabetes Care · doi:10.2337/diacare.25.3.623 · Cited by 42
Self-citationCow's Milk–Free Diet Does Not Prevent Diabetes in NOD Mice
Paxson, J. A., Weber, J. G., & Kulczycki, A. (1997) · Diabetes · doi:10.2337/diab.46.11.1711 · Cited by 41
Should We Screen for Risk of Type 1 Diabetes?
Knip, M. (2008) · Diabetes Care · doi:10.2337/dc08-0023 · Cited by 11
Self-citationProtein-free diets do not protect high-incidence diabetes-prone BioBreeding rats from diabetes
Simonson, W., Ramanathan, S., Bieg, S., Poussier, P., & Lernmark, Å. (2002) · Metabolism · doi:10.1053/meta.2002.31979 · Cited by 9
Flagged first, then by citations
Cited by
Sorted by citations
Atkinson, M. A., Eisenbarth, G. S., & Michels, A. W. (2014) · The Lancet · doi:10.1016/s0140-6736(13)60591-7 · Cited by 2,931
Commensal microbiota and myelin autoantigen cooperate to trigger autoimmune demyelination
Berer, K., Mues, M., Koutrolos, M., Rasbi, Z. A., Boziki, M., Johner, C., Wekerle, H., & Krishnamoorthy, G. (2011) · Nature · doi:10.1038/nature10554 · Cited by 1,251
Diabetes mellitus: The epidemic of the century
Kharroubi, A. (2015) · World Journal of Diabetes · doi:10.4239/wjd.v6.i6.850 · Cited by 1,352
Kostic, A. D., Gevers, D., Siljander, H., Vatanen, T., Hyötyläinen, T., Hämäläinen, A., Peet, A., Tillmann, V., Pöhö, P., Mattila, I. M., et al. (2015) · Cell Host & Microbe · doi:10.1016/j.chom.2015.01.001 · Cited by 1,198
Self-citationEnvironmental risk factors for type 1 diabetes
Rewers, M., & Ludvigsson, J. (2016) · The Lancet · doi:10.1016/s0140-6736(16)30507-4 · Cited by 676
Metadata
- Authors
- Knip, M., Virtanen, S. M., Seppä, K., Ilonen, J., Savilahti, E., Vaarala, O., Reunanen, A., Teramo, K., Hämäläinen, A.-M., Paronen, J., Dosch, H.-M., Hakulinen, T., & Åkerblom, H. K.
- Affiliations
- University of Helsinki (FI)
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2010-11-11
- Volume
- 363
- Issue
- 20
- Pages
- 1900-1908
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- PMC
- PMC4242902
- OpenAlex
- W1227874083
- Cited by
- 281
- References
- 29
- Citations by year
- 2026: 5 · 2025: 3 · 2024: 11 · 2023: 7 · 2022: 11 · 2021: 12 · 2020: 11 · 2019: 13 · 2018: 17 · 2017: 17 · 2016: 19 · 2015: 20 · 2014: 28 · 2013: 35 · 2012: 39
- FWCI
- 18.91
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- STM:n Hallinnonalan avoin julkaisuarkisto (Julkari) (submittedVersion)
- Funders
- Mead Johnson Nutrition
- Helsingin Yliopisto
- Helsingin ja Uudenmaan Sairaanhoitopiiri
- European Commission (BMH4-CT96-0233)
- Academy of Finland
- Novo Nordisk
- Novo Nordisk Fonden
- Tays
- Diabetestutkimussäätiö
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (U01HD040364)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Health Sciences › Nursing › Nutrition and Dietetics › Infant Nutrition and Health
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- type 1 diabetes, islet autoimmunity, dietary intervention, breast milk supplementation, diabetes-associated autoantibodies, insulin autoantibodies, glutamic acid decarboxylase, IA-2, zinc transporter 8, islet cell antibodies, HLA-DQ2/DQ8, genetic susceptibility, infant feeding
- MeSH terms
- Animals, Autoantibodies, Caseins, Child, Diabetes Mellitus, Type 1, Double-Blind Method, Histocompatibility Testing, Humans, Infant, Infant, Newborn, Milk, Milk, Human, Pilot Projects, Biomarkers, Autoimmunity, Disease Progression, Genetic Predisposition to Disease, Infant Formula, Insulin-Secreting Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
